ReviewFolia microbiologica2026
Harnessing the power of abiotic inducers to enhance fungal secondary metabolite production: a review.
Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Fungal-Based Biogenic Silver Nanoparticles: Synthesis, Mathematical Modeling and Application.Molecules (Basel, Switzerland) · 2026Article
- ROS-CaArchives of microbiology · 2026Article
- Integrating Free Amino Acid Profiles with Flavoromics to Characterize the Flavor Characteristics of DifferentFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungi and yeasts are prolific producers of structurally diverse secondary metabolites with extensive applications in pharmaceutical, food, agricultural, and industrial biotechnology. Conventional strategies to enhance metabolite production have largely relied on rational metabolic and genetic engineering; however, these approaches are often constrained by incomplete pathway knowledge, metabolic burden, regulatory complexity, and biosafety concerns associated with genetically engineered microorganisms. In recent years, the application of abiotic stresses has emerged as a powerful and complementary strategy to activate silent biosynthetic gene clusters and redirect metabolic fluxes without direct genetic manipulation. This review provides a comprehensive overview of abiotic stress-based approaches for enhancing secondary metabolite production in fungi and yeasts. We systematically examine the effects of major stress categories, including osmotic, oxidative, pH, solvent-induced, radiation, and heavy metal stresses, on microbial metabolism and secondary metabolite biosynthesis. Evidence from diverse fungal and yeast models demonstrates that controlled stress exposure can significantly increase the yield and diversity of metabolites such as pigments, carotenoids, antibiotics, statins, lipids, organic acids, osmolytes, and antioxidants. Importantly, this review highlights that stress responses are highly strain- and metabolite-specific, underscoring the need for tailored stress packages optimized for individual industrial strains or target compounds. We also discuss universally stress-responsive metabolites, such as proline and trehalose, which consistently accumulate under multiple stress conditions and represent promising leverage points for metabolic improvement. Overall, abiotic stress-induced metabolic engineering offers a cost-effective, flexible, and non-GMO strategy to enhance fungal and yeast metabolite production, with significant implications for industrial biotechnology and natural product discovery.
Indexed as
Identifiers
41670828What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.